Premark Pharma

Treatments of ophthalmic diseases

The company specializes in the development and commercialization of topical treatments for inflammatory diseases of the skin, eye, mucosae, and mucocutaneous surfaces, enabling doctors to cure patients suffering from unmet conditions.

Domain

Topical Ophthamology

First Partnered

Seed

Current Status

Active

Investors

Tom Mather

Leadership

John Wayne, CEO
Ann Smith, CTO

HQ

Distributed

In the News